Holen Sie sich die Stockscreener-App
0.343
6.03%
-0.022
Handel nachbörslich:
.35
0.007
+2.04%
Schlusskurs vom Vortag:
$0.365
Offen:
$0.363
24-Stunden-Volumen:
1.65M
Relative Volume:
0.25
Marktkapitalisierung:
$9.76M
Einnahmen:
$9.37M
Nettoeinkommen (Verlust:
$-8.45M
KGV:
-0.4235
EPS:
-0.81
Netto-Cashflow:
$-7.27M
1W Leistung:
+17.10%
1M Leistung:
+45.09%
6M Leistung:
-48.42%
1J Leistung:
-86.44%
1-Tages-Spanne:
$0.331
$0.375
1-Wochen-Bereich:
$0.2893
$0.375
52-Wochen-Spanne:
$0.1639
$2.9893
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Vergleichen Sie BIAF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.343 | 8.34M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer Diagnostic - BioSpace
bioAffinity Technologies obtains Canadian patent for lung cancer spit test - Mugglehead Magazine
Is bioAffinity Technologies Inc. a good long term investmentLightning-fast capital gains - jammulinksnews.com
What drives bioAffinity Technologies Inc. stock priceRapid profit acceleration - Autocar Professional
What drives bioAffinity Technologies Inc. Equity Warrant stock priceExceptional risk-adjusted gains - jammulinksnews.com
Is bioAffinity Technologies Inc. Equity Warrant a good long term investmentHigh-yield investments - jammulinksnews.com
bioAffinity Technologies Secures Canadian Patent for Lung Cancer Detection - TipRanks
Published on: 2025-07-22 10:16:37 - Newser
bioAffinity Technologies secures Canadian patent for lung cancer test By Investing.com - Investing.com India
What analysts say about bioAffinity Technologies Inc. Equity Warrant stockUnmatched market gains - jammulinksnews.com
What analysts say about bioAffinity Technologies Inc. stockMarket-crushing stock picks - jammulinksnews.com
bioAffinity Technologies Inc. Equity Warrant Stock Analysis and ForecastHigh-impact stock picks - jammulinksnews.com
Why bioAffinity Technologies Inc. stock is on top investor watchlistsFree Investment Community - Newser
bioAffinity Technologies Inc. Stock Analysis and ForecastOutstanding stock performance - jammulinksnews.com
Published on: 2025-07-17 23:17:46 - Newser
bioAffinity Technologies Secures Chinese Patent for Lung Cancer Detection - The Globe and Mail
Before You Invest, Make Sure You Check This BioAffinity Technologies Inc (NASDAQ: BIAF) Analysis - Stocksregister
Why bioAffinity Technologies Inc. Equity Warrant stock attracts strong analyst attentionExpert Backed Predictions - Newser
bioAffinity Technologies Announces Notification of China Patent Award for Company’s Noninvasive Lung Cancer Diagnostic - BioSpace
How bioAffinity Technologies Inc. Equity Warrant stock performs during market volatilityAI Powered Stock Call - Newser
bioAffinity receives patent award for lung cancer diagnostic in China. - AInvest
Why bioAffinity Technologies Inc. stock attracts strong analyst attentionFree Best Stocks to Buy Today - Newser
How bioAffinity Technologies Inc. stock performs during market volatilityHigh Win Rate Stock Ideas - Newser
What makes bioAffinity Technologies Inc. stock price move sharplyFree Predictions - Newser
BioAffinity receives China patent for noninvasive lung cancer diagnostic - TipRanks
What makes bioAffinity Technologies Inc. Equity Warrant stock price move sharplyTargeted 200 Percent Gain - Newser
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):